Endoscopic Vessel Harvesting Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Endoscopic Vessel Harvesting Market Report is Segmented by Product (EVH Systems, Endoscopes, and Accessories), Usability (Disposable and Reusable), Application (Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD)), and Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America). The Report Offers the Value (USD) for all the Above Segments.

Endoscopic Vessel Harvesting Market Size

Endoscopic Vessel Harvesting Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 0.5 Billion
Market Size (2029) USD 0.58 Billion
CAGR (2024 - 2029) 3.94 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Endoscopic Vessel Harvesting Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Endoscopic Vessel Harvesting Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Endoscopic Vessel Harvesting Market Analysis

The Endoscopic Vessel Harvesting Market size is estimated at USD 0.5 billion in 2024, and is expected to reach USD 0.58 billion by 2029, growing at a CAGR of 3.94% during the forecast period (2024-2029).

Key drivers fueling market growth include the escalating prevalence of cardiovascular diseases like coronary artery disease and peripheral artery disease, a growing preference for minimally invasive harvesting due to its benefits over traditional methods, and the expanding geriatric demographic.

The global market for endoscopic vessel harvesting is primarily driven by the significant burden of coronary artery disease (CAD) worldwide. According to a study in the April 2024 issue of the Journal of the American College of Cardiology, the global prevalence of CAD stood at 315 million cases in 2022. This substantial burden underscores the demand for endoscopic vessel harvesting in treating and managing CAD, fueling market growth.

The geriatric population, which is more susceptible to coronary and peripheral artery diseases, is expected to be a significant market growth driver. According to the UN World Population Prospects 2022, the global population aged 65 and above is expected to climb from 10% in 2022 to 16% by 2050. By 2050, the number of individuals aged 65 and above is forecasted to surpass twice the count of children under 5 and nearly match those under 12.

The uptick in hospitals adopting endoscopic vessel harvesting procedures further propels the market growth. For instance, in July 2022, the Liverpool and Chest Hospital introduced the endoscopic vein harvesting (EVH) procedure in the UK. Such introductions create demand for associated products, bolstering market growth.

Initiatives taken by market players, such as the establishment of new manufacturing facilities in different regions across the world to increase their foothold, also propel market growth. For instance, in September 2022, Terumo opened its new Cardiovascular manufacturing plant in La Lima, Cartago, Costa Rica. Terumo deals with endoscopic vessel harvesting products through its cardiovascular segment.

Owing to factors such as the surge in cardiovascular diseases, the rising aging population, the benefits of minimally invasive procedures, and new launches and initiatives taken by market players, the market is expected to grow during the forecast period. However, challenges like competing treatment options and unfavorable reimbursement scenarios could temper this growth.

Endoscopic Vessel Harvesting Market Trends

The Coronary Artery Disease Segment is Expected to Hold a Significant Share in the Market Over the Forecast Period

Coronary artery disease (CAD) is a narrowing or blockage of coronary arteries, usually due to plaque buildup. The rising prevalence of coronary artery disease (CAD) and the rising geriatric population are driving the growth of the segment.

According to an article published by PubMed Central in July 2022, coronary artery disease, also known as coronary heart disease, is often caused by decreased myocardial perfusion that causes issues such as angina, myocardial infarction (MI), and heart failure. CADs account for one-third to half of all cardiovascular diseases. Thus, due to the high burden of coronary artery disease, the segment is expected to experience growth during the forecast period.

According to an article reviewed by Healthdirect Australia in June 2022, coronary heart disease was the most common cause of death in Australia, and risk factors for this included smoking, excessive alcohol consumption, lack of exercise, social isolation, and being overweight or obese. Thus, the high burden of CAD in various countries is expected to boost the adoption of endoscopic vessel harvesting procedures for its treatment.

The increasing risk of CAD with increasing age and the rising geriatric population globally are other major factors driving segment growth. For instance, according to an article updated by NCBI in November 2022, the incidence of CAD rises with age, regardless of gender. Additionally, the increasing investment in CAD research is expected to introduce advanced endoscopic vessel harvesting procedures to the market.

Thus, factors such as the rising burden of CAD, the increasing geriatric population, and the increasing investment in research for CAD are expected to boost segmental growth.

Endoscopic Vessel Harvesting Market:  Research Spending on Coronary Heart Disease (in million), United States, 2021-2023

North America Holds the Largest Share of the Market Over the Forecast Period

North America is expected to hold a significant share of the market due to the rising burden of diseases such as coronary artery disease and peripheral arterial disease, coupled with the rising geriatric population and product launches by key market players.

According to the data published by Statistics Canada in July 2022, it was estimated that around 7,330,605 people were aged 65 years or older in Canada, accounting for 18.8% of the total population. As the geriatric population is more prone to peripheral arterial diseases, the rising geriatric population is expected to increase the demand for endoscopic vessel harvesting procedures, thereby driving market growth in the region.

The high burden of coronary artery disease in the United States, as highlighted in a May 2024 article from Current Problems in Cardiology, stood at 4.9% among US adults in 2022. This significant burden of CADs directly fuels market growth.

The entry of new players in the region also drives the growth of the market. For instance, in August 2022, CardioPrecision introduced its CoreVista devices for Endoscopic Vessel Harvesting (EVH) to the US market.

Thus, factors such as the rising burden of CAD and PAD and the increasing geriatric population are expected to boost segmental growth.

Endoscopic Vessel Harvesting Market - Growth Rate by Region

Endoscopic Vessel Harvesting Industry Overview

The endoscopic vessel harvesting market is consolidated in nature. There are very few companies that significantly contribute to market growth. Product innovation and R&D activities to develop advanced technologies boost the market's growth. The key players in the market are adopting various strategic moves to sustain the intense competition. Major players in the market include Getinge AB, Terumo Corporation, LivaNova PLC, Medical Instruments SpA, and KARL STORZ SE & Co. KG.

Endoscopic Vessel Harvesting Market Leaders

  1. Getinge AB

  2. Terumo Corporation

  3. LivaNova PLC

  4. Medical Instruments Spa

  5. KARL STORZ SE & Co. KG

*Disclaimer: Major Players sorted in no particular order

Endoscopic Vessel Harvesting Market Concentration
Need More Details on Market Players and Competitors?
Download PDF

Endoscopic Vessel Harvesting Market News

  • May 2024: The Asia-Pacific EVH Summit in Singapore was inaugurated by Getinge. This educational event provided clinicians with valuable insights and skills.
  • March 2024: Getinge received US Food and Drug Administration (FDA) 510(k) clearance for Vasoview Hemopro 3 endoscopic vessel harvesting (EVH) solutions.

Endoscopic Vessel Harvesting Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Global Burden of Cardiovascular Diseases

      2. 4.2.2 Growing Preference for Minimally Invasive Harvesting Procedures

    3. 4.3 Market Restraints

      1. 4.3.1 Availability of Alternative Treatment Methods

      2. 4.3.2 Poor Reimbursement Scenario

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Buyers/Consumers

      2. 4.4.2 Bargaining Power of Suppliers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 5.1 By Product

      1. 5.1.1 EVH Systems

      2. 5.1.2 Endoscopes

      3. 5.1.3 Accessories

    2. 5.2 By Usability

      1. 5.2.1 Disposable

      2. 5.2.2 Reusable

    3. 5.3 By Application

      1. 5.3.1 Coronary Artery Disease (CAD)

      2. 5.3.2 Peripheral Artery Disease (PAD)

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Getinge AB

      2. 6.1.2 Terumo Corporation

      3. 6.1.3 Livanova PLC

      4. 6.1.4 KARL STORZ SE & Co. KG

      5. 6.1.5 Saphena Medical

      6. 6.1.6 Medical Instruments SpA

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Endoscopic Vessel Harvesting Industry Segmentation

As per the scope of the report, endoscopic vessel harvesting devices are used to obtain one or more healthy vessels from the patient's leg or arm to be used as conduits to bypass obstructed blood vessels in the cardiac or peripheral region.

The endoscopic vessel harvesting market is segmented by product, usability, application, and geography. By product, the market is sub-segmented into EVH systems, endoscopes, and accessories. By usability, the market is sub-segmented into disposable and reusable. By application, the market is sub-segmented into coronary artery disease (CAD) and peripheral artery disease (PAD). By geography, the market is sub-segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (in USD) for all the above segments.

By Product
EVH Systems
Endoscopes
Accessories
By Usability
Disposable
Reusable
By Application
Coronary Artery Disease (CAD)
Peripheral Artery Disease (PAD)
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Endoscopic Vessel Harvesting Market Research FAQs

The Endoscopic Vessel Harvesting Market size is expected to reach USD 0.5 billion in 2024 and grow at a CAGR of 3.94% to reach USD 0.58 billion by 2029.

In 2024, the Endoscopic Vessel Harvesting Market size is expected to reach USD 0.5 billion.

Getinge AB, Terumo Corporation, LivaNova PLC, Medical Instruments Spa and KARL STORZ SE & Co. KG are the major companies operating in the Endoscopic Vessel Harvesting Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Endoscopic Vessel Harvesting Market.

In 2023, the Endoscopic Vessel Harvesting Market size was estimated at USD 0.48 billion. The report covers the Endoscopic Vessel Harvesting Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Endoscopic Vessel Harvesting Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Endoscopic Vessel Harvesting Industry Report

Statistics for the 2024 Endoscopic Vessel Harvesting market share, size and revenue growth rate, created by Mordor Intelligenceā„¢ Industry Reports. Endoscopic Vessel Harvesting analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Endoscopic Vessel Harvesting Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)